Area
Bookmark and Share text size: A A A

Duke, LabCorp OK deal on biostorage

Wednesday, March 04, 2009 3:00 AM | Printer friendly version Printer friendly version | E-mail to a friend E-mail to a friend |



By Emily Ford

eford@salisburypost.com

Laboratory Corporation of America and Duke University reached a deal Tuesday regarding operation of a high-tech storage facility near the N.C. Research Campus and management of up to 10 million human biological samples.

Burlington-based LabCorp and Duke are collaborating on the 40,000-square-foot biorepository at U.S. 29 and Chipola Road, which is under construction by campus developer Castle & Cooke North Carolina and should open later this year.

The biorepository will store samples for academic centers, research organizations, health-care providers and biotechnology companies.

Duke will use the facility to house samples collected from 50,000 Cabarrus County and Kannapolis residents who enroll in the university's long-term medical research study.

The study, named for campus founder David Murdock, uses genomic technologies to identify patterns across large groups of people with chronic diseases like arthritis and diabetes. Eventually, scientists hope to discover new ways to diagnose and treat disease.

LabCorp chief executive officer David King said the biorepository will lead to new diagnostic tests that will benefit patients.

The company also considers the biorepository an important service for its commercial clients, King said in a statement.

The facility will offer both a high-security storage environment and on-site nucleic acid and sample preparation capabilities.

Companies and universities that pay to store samples in the biorepository could also make use of the nearby Core Laboratory at the Research Campus, which features some of the world's best instruments for analysis and biomarker development.

Personalized and genomic medicine are the future of healthcare and "require an ability to store and analyze large quantities of tissue and blood samples," said Dr. Victor Dzau, chancellor for health affairs and chief executive officer for Duke University Health System.

LabCorp commercializes diagnostic technologies and offers clinical tests ranging from routine blood analyses to HIV and genomic testing.




If you would like to subscribe to the Salisbury Post, click here.

Comments

Notice about comments:

Salisburypost.com is pleased to offer readers the ability to comment on stories. We expect our readers to engage in lively, yet civil discourse. Salisburypost.com cannot promise that readers will not occasionally find offensive or inaccurate comments posted in the comments area. Responsibility for the statements posted lies with the person submitting the comment, not Salisburypost.com. If you find a comment that is objectionable, please click "report abuse" and we will review it for possible removal. Please be reminded, however, that in accordance with our Terms of Use and federal law, we are under no obligation to remove any third party comments posted on our website.
DO NOT POST:
* Potentially libelous statements or damaging innuendo.
* Obscene, explicit, or racist language.
* Personal attacks, insults or threats.
* The use of another person's real name to disguise your identity.
* Comments unrelated to the story.

Full terms and conditions can be read here

Salisbury Post is proud to offer our users enhanced commenting features. You can now build user-to-user connections, follow friend's recent posts, add an avatar that fits your personality, and more.




Most Popular Stories
  • Photos
  • Videos
  • Forums
  • Blogs




  
Poll
The current 3.4 percent interest rate on federally subsidized student loans will rise to 6.8 percent on July 1 if Congress does not extend the lower rates. What should Congress do?
  • Extend lower rate
  • Let rate rise



 
 
  
  
© 2011 Post Publishing Company, Inc. |